Blog
News February 19, 2021
Iterion Therapeutics Lands $17M Series B
– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing. – The round was led by Lumira Ventures, with the participation of existing investors, including Santé Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.
News February 19, 2021
Leverage Edu raises $6.5 million to help Indian students land in top colleges abroad
News February 18, 2021
Peak AI nabs $21M for a platform to help non-tech companies make AI-based decisions
News February 18, 2021
Experiment Tracking Platform Company Weights and Biases Raises $45 Million
News February 18, 2021
Distributed Data And Code Sharing Platform Vendia Raises $15.5 Million
Ratings & lists February 18, 2021